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Objective: To study the safety and clinical outcomes of ReLEx SMILE with accelerated cross-linking 
in eyes with thin cornea. 
Materials and Methods: Fifty-four thin cornea with corrected distance visual acuity 20/25 or better, 
stable refraction of at least 1 year, age 21 years or older, and residual corneal thickness of greater than 
400 mm before performing collagen crosslinking were studied. Following the removal of lenticule, 
0.25% riboflavin in saline was injected into the interface and allowed to diffuse for 60 seconds. 
Finally, eye was exposed to UV-A radiation of 45mW/cm2 for 75 seconds through the cap. Total 
energy delivered was 3.4 J/cm2. 
Results: 54 eyes of 27 patients with mean age of 25.22 ± 2.67 years were treated. Mean follow-up 
was 6 months. Mean spherical equivalent (SE) was −5.58 ± 1.22D preoperatively and -0.111 ± 
0.636D postoperatively. The mean central corneal thickness (CCT) and keratometry changed from 
498.39 ± 11.79 µm to 417.85 ± 12.82 µm and 45.47 ± 0.68 D to 41.13 ± 1.13D, respectively. Mean 
uncorrected visual acuity (UCVA) was 20/25 or better in all eyes. No eyes lost lines of corrected 
distant visual acuity (CDVA). There were no complications like haze, keratitis, ectasia, or regression. 
Conclusion: Based on the initial clinical outcome it appears that SMILE Xtra may be a safe. 
Although further follow-up and larger samples are needed to fully confirm these findings, the results 
suggest that combined small-incision lenticule extraction and intrastromal corneal collagen 
crosslinking (CXL) are a promising treatment option for patients for whom conventional laser 
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Introduction 
Small-incision lenticule extraction (SMILE) is 
a lately expanded corneal refractive method 
that has been appeared to be effective, safe and 
predictable in   myopic eyes.1-3 corneal 
refractive surgery in thin corneas or borderline 
topography is a very difficult decision for 
surgeons, with the most dreaded 
inconvenience being postoperative ectasia or 
return of refraction.4,5 Corneal collagen 
crosslinking (CXL) has been demonstrated to 
be an efficient method to reinforcement and 
consolidation the cornea in type of ectasia 
after corneal refractive surgery.6,7 Another 
novel utilization of CXL is the mix of this 
system with, laser-assisted in situ 
keratomileusis (LASIK) and photorefractive 
keratectomy(PRK) 8,9 that has better  and 
safety outcomes in patients with borderline  
topography and thin cornea for corneal 
refractive surgery.9 
A ReLEx® SMILE laser eye surgery is a 
flapless and one-step, one laser only procedure 
that creation of a lenticule by femtosecond 
laser and pulled out from small incision. This 
method has notable benefits over LASIK with 
CXL method, as there are fewer complications 
such as dry eye, induction of aberrations, 
decreased biomechanical stability and no flap 
related complications.10 The combination of 
these ReLEx SMILE with collagen cross-
linking is to prevent the occurrence of ectasia 
in high-risk cornea. The main purpose of this 
study was to evaluate the efficacy and safety 
of surgery during the follow -up period. 
 
Materials and Methods 
The tenets of the Declaration of Helsinki were 
followed. Before starting the study, we 
obtained ethical approval from the Iran 
University of Medical Sciences. The procedure 
and complications of the surgery were 
explained to the patients and all patients 
signed up with full consent to participate in the 
study. 
Inclusion criteria included: Age greater than or 
equal to 21 years, spherical myopia ≥-3.00 
diopters (D) and myopic astigmatism -4.75 
D≤, minimum corneal thickness > 480 µm. 
Prior to surgery, a thorough pre-surgically 
ocular examination was accomplished to 
confidence no past or present ocular pathology 
except refractive errors.  
Exclusion criteria included: patients with 
corneal thickness < 480 µm, keratoconus, 
hyperopic and hyperopic astigmatism, history 
of riboflavin allergy, past history of chemical 
injury and herpes infection, concurrent eye 
infection, long-term use of oral or topical 
steroids and  pregnancy. 
All patients underwent complete 
ophthalmologic examinations before surgery, 
including uncorrected visual acuity (UCVA) 
and best corrected  distant visual 
acuity(CDVA) by  ETDRS charts at 4 m, 
manifest and cycloplegic refraction by 
automated kerato refractometry (KR1; Topcon
, Tokyo, Japan), applanation tonometry, 
fundus examination, slit lamp biomicroscopy, 
topography (Orbscan IIz, Baush & Lomb), 
contrast sensitivity(CS) by CVS-IOOO. We 
examined the patients on day 1 and 2, 4 and 6 
months post-operatively.  
In postoperative examinations UCVA, CDVA, 
contrast sensitivity, efficacy index, corneal 
thickness, safety index, and the predictability 
of the correction, topography were performed. 
 
Surgical Technique 
All surgeries were performed by the same 
trained surgeon (F.D). In the primary stage, 
patients underwent ReLEx SMILE was 
accomplished utilizing standard surgical 
techniques. Visumax femtosecond laser 
system (Carl Zeiss Meditec, Jena) was utilized 
to make a refractive lenticule with cap 
diameter 7–7.5 mm, thickness of 110 𝜇m and 
optical zone 6 to 6.5 mm, with a transition 
zone of 0.1mm, spot and tracking distance, 
2.0–3.0 𝜇m, cut energy, 1.4 𝜇J then the cut 
refractive lenticule removed from through a 
2mm superior incision at 10 o’clock position 
(for right eye) and 12 o’clock position (for left 
eye),. Following the removal of lenticule, 
0.25% riboflavin in saline (VibeX Xtra, 
Avedro) was injected into the interface and 
allowed to diffuse for 60 seconds. Finally, eye 
was exposed to UV-A radiation of 45mW/cm2 
for 75 seconds through the cap with total 
energy delivered 3.4 J/cm2 utilizing the CXL-
365 vario system (Schwind eye-tech-solutions 
GmbH & Co. Kleinostheim, Germany). No 
complications were observed during surgery. 
Postoperative medical and pharmaceutical care 
included topical  levofloxacin 0.3% (Oftaquix, 
Bausch and Lomb, Milan, Italy) 4 times for 3 
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(Betasonit, Sina Darou Company, Tehran, 
Iran) 4 weeks, and lubricants 4–6 times for 4 
weeks or more. 
Statistical Analysis: After data collection, 
data analysis before surgery and 2, 4 and 6 
month's post-surgery and according to the 
objectives of the study. We used a parametric 
one-way repeated measure ANOVA test to 
assess the statistically significant changes in 
the outcomes overtime at 0.05 significance 
level. We used the Stata Version 15 statistical 
program (Stata- Corp, College Station, TX, 
USA) to the statistical analysis. 
 
Results 
The investigation included 54 eyes from 27 
patients of both sexes. Demographic and 
preoperative baseline data are summarized in 
table 1. 
 
In the first days after the surgery, all corneas 
were clear and all patients were comfortable 
and did not report symptoms. We didn't see 
any side effects like keratitis, ectasia, deep 
lamellar keratitis and epithelial ingrowth the 
entire 6 months follow-up period. After one 
month of surgery, four eyes of two patients 
were created late mild haze and a decease 
CDVA by two line which later recovered 
within four months after application topical 
steroids. 
Visual Acuity, Safety, Efficacy, Stability 
and Predictability: Table 2 shows the visual 
acuity during the follow-up period. After 6 
months follow-up, all (100%) eyes were 20/25 
or better, 21 eyes (38.8%) had no change in 
CDVA, 31 eyes (57.4%) more than gained 1 
line. Four eyes lost 2 line at one month follow-
up, which improved to 20/20 visual acuity at 4 
months. From month 2 onwards, UCVA, 
BCVA, and SE variables showed stability.  
Generally mean safety index (postoperative 
CDVA/preoperative CDVA) was 1.03 and 
mean efficacy index (postoperative UDVA/ 
preoperative CDVA) was 1.09 at the last 
follow-up visit. High levels of predictability 
were observed after surgery, with 30 eyes 55% 
at ±0.25 and 38 eyes 70% at ±0.50 after 6 
months of surgery. (Figure 1) 
 
 
Keratometry and Central Corneal 
Thickness: Table 3 shows keratometric and 
pachymetric changes over the follow-up 




Although there was a drop in the contrast for 
all spatial frequencies, it remained in the 
normal acceptable range and showed a trend 
towards recovery in all subjects at the end of 
the mean follow-up. In all postoperative visits 




SMILE surgery has theoretical advantages 
such as minimal effect on corneal strength, 
flapless as a result, no flap complications. 
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saving technique when contrasted with LASIK 
(In SMILE per diopter 13 microns and 17 
microns LASIK). As a result, SMILE is a 
more appropriate option for treating thinner 
corners, high myopia, and those with abnormal 
topography. 11-14 
However, there have been reports of corneal 
ectasia following SMILE surgery.15-19 
PRK and LASIK weaken the cornea by 14% to 
33%, which can increase the risk of ectasia for 
this reason; this possibility can be minimized 
by methods such as combining with CXL. 20, 
21 
Past studies have reported the combination of 
LASIK or PRK with CXL as effective and 
safe. 22 This will increase the number of 
patients eligible for surgery. 
In this study, we used a new method of 
combining SMILE with CXL to minimize side 
effects and increase efficacy. In 2009, 
Kanellopoulos et al 23 demonstrated, using a 
femtosecond laser, which created corneal 
pocket in the stroma of patients with mild 
keratoconus and riboflavin injection, it 
increased wound healing and efficacy and 
minimized complications such as infection. He 
proposed an option to the regular CXL with 
the benefit of not removing the epithelium 
subsequently having quicker healing, better 
comfort, also, less possibility of infection. 
Combining SMILE procedure (SMILE Xtra) 
with CXL has utilized a similar idea. 
Preliminary results published of SMILE Xtra 
demonstrate the method to be effective and 
safe on the short courses. There are not many 
articles in the literature covering this 
technique, and they all need long-term follow-
up .24- 26 
One of the benefits of the SMILE Xtra is that 
CXL is performed for the underlying stroma 
and the overlying cap; where LASIK Xtra, just 
under stromal done because it may cause 
wrinkles flap and flap displacement problem to 
be touched.  
Treating thin or borderline topography corneas 
with CXL as prophylaxis must be different 
from therapeutic protocols. The goal is to 
stabilize the cornea with the least amount of 
energy. Excessive energy causes interfere with 
vision and haze, however, if energy is low, it 
cannot stabilize and create strong connections 
in the stroma. For the treatment of ectasia, 
there are long-term follow-up for CXL 
protocols that have confirm to be effective and 
safe.27 Although, in order to prophylaxis for 
the treatment of high-risk eyes, there is still no 
standard protocol with different regimens. In 
LASIK Xtra method, various researchers have 
utilized 30 mW/cm2 for various lengths with a 
total energy of 1.8 to 5.4 J/cm2, and each one 
of those various regimens confirm to be 
effective and safe. 9, 28 Also, for the 
prophylaxis treatment in keratoconus, the 
minimum amount of energy to strengthen the 
cornea is yet unbeknown. In our study, eye 
was exposed to UV-A radiation of 45mW/cm2 
for 75 seconds through the cap with total 
energy delivered 3.4 J/cm2 utilizing the CXL-
365 vario system (Schwind eye-tech-solutions 
GmbH & Co. Kleinostheim, Germany).	 It is 
easy to cross-link because of the cap and 
epithelium remains intact .We suggested that a 
high concentration of 45mW / cm2 would 
permit adequate radiation to reach the stroma 
to be effective for cross-linking, because the 
epithelium can absorb a significant amount of 
UV-A radiation.29 
With a prophylactic system, we planned for 
accomplishing an ideal energy, which is 
neither excessively high as is utilized for 
ectasia (>5.4 J/cm2) nor too low to be in any 
way successful. 
We used the most elevated fluency of the 
method and saw our routine as safe as it didn't 
outcome in epithelial defects, punctate 
keratitis, endothelial toxicity or deep lamellar 
keratitis. 
We utilized VibeX Xtra 0.25% in saline, 
which is prescribed for intrastromal usage as it 
quickly accomplishes high condensations in 
the stroma. Since it is without dextran, the 
dissemination into more profound layers is 
accomplished as right on time as 60 seconds 
after usage. This aides in particular position of 
riboflavin in the stroma with the goal that it 
assimilates and actuates UVA light and 
accomplishes cross-connecting without 
representing a danger to the basic essential 
structures because of any wanderer radiation. 
We watched the topographic and refractive 
constancy of the strategy to be superb and all 
around kept up at six months. None of the 
patients' eyes had clinical or topographic, 
regression, or evidence of postoperative 
ectasia. There was no decrease in CDVA in 
any of them and they did not need glasses 
during the follow-up period. Drop in CS and 
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recovery of both transient issues during 
follow-up. 
Preliminary outcomes recommend that it is 
safe to combine CXL with SMILE for future 
utilizations to prevent keratoconus 
.Limitations of this study include: lack of 
equipment for examine the changes in 
biomechanics and impact of the excessive 
cross-connecting on keratocytes with confocal 
microscopy, small number of patients 
participating in the project and its short-term 
follow-up. 
In conclusion, combining SMILE Xtra with 
CXL is a promising method to keep ectasia in 
patients with thin cornea and borderline 
topography. With at risk for ectasia. It is a 
simple and safe strategy that can be proposed 
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